- Diagnostics
- Thursday, 13 Feb 2020
DERMALOG Provides the World's First Biometric Border Control System With Integrated Fever Detection
As the first country in the world, Thailand has introduced a pilot for a new fever detection system, fully integrated into its biometric border control. The new solution was demonstrated to the press by the Thai Immigration Bureau deputy commissioner, Pol Maj-Gen Surapong Chaichan at Don Mueang International Airport in Bangkok on February 12.
From now on, the biometric border control system in Don Mueang can capture not only fingerprints and faces, but also measures the body temperature of travelers who pass through the related counters. The temperature is displayed on the border officer's screen and, if someone with fever is detected, the officer is automatically informed and can send the affected person for a health check.
DERMALOG, the supplier of the biometric border control system, has developed a special fever camera, which is fully integrated into the Thai entry-exit system. It automatically measures the exact temperature of the traveler while standing in front of the border counter. The high fever-detection accuracy at a distance of up to 1.5 m, is one of the system's outstanding features.
Border counters are the perfect spot for such fever checks, as travelers stop here one by one for a moment. DERMALOG's solution provides more accurate and precise results than camera systems that capture several travelers simultaneously. This makes the Thai borders more secure, also against the coronavirus.
Related Industry Updates
China criticizes Indian to stop using Chinese coronavirus test kits
Apr 28, 2020
QuEST Global Enhances its Lung Nodule Detection Solution Using Microsoft Azure IoT Central, Azure IoT Edge and Azure Machine Learning
Jun 12, 2020
PSA Test Explained: What It Is, How It Works, and Why It Matters
Mar 27, 2026
ArcherDX Announces Strategic Collaboration with AstraZeneca to Develop Personalized Cancer Monitoring (PCM) Assays for Minimal Residual Disease (MRD)
May 26, 2020
Ascend to Perform Antibody Testing for COVID-19
Jun 02, 2020
qFIBS Demonstrates Suitability for Nonalcoholic Steatohepatitis (NASH) Assessment in Clinical Trials and Patient Care with Full Quantification of All Crucial Histopathological Features
Nov 11, 2019
ZEISS and Kyoto University consolidate strategic partnership
Nov 07, 2019